期刊文献+

多西他赛治疗前列腺癌的效果及其对患者P-糖蛋白表达的影响 被引量:4

The Efficacy of Docetaxel in the Treatment of Prostate Cancer and Its Effect on the Expression of P-gp in Patients
下载PDF
导出
摘要 目的分析多西他赛治疗前列腺癌的效果及其对患者P糖蛋白(P-gp)表达的影响。方法选取我院收治的前列腺癌患者78例,按随机数字法分为两组,对照组采用比卡鲁胺治疗,研究组采用多西他赛联合比卡鲁胺治疗,比较两组患者的治疗效果以及P-gp的表达。结果研究组治疗有效率为92.3%,明显高于对照组的38.5%(P<0.05);研究组不良反应发生率为23.1%,对照组为25.6%,差异无统计学意义(P>0.05);治疗前两组患者的生活质量无明显差异(P>0.05),治疗后均有所提高,且研究组躯体、生理、心理和社会功能评分明显高于对照组(P<0.05);治疗后,研究组P-gp表达阳性患者明显少于对照组(P<0.05)。结论针对前列腺癌患者应用多西他赛联合比卡鲁胺治疗,可更有效地控制和缓解病情,提高生活质量,改善P-gp表达。 Objective To explore the efficacy of docetaxel in the treatment of prostate cancer and its effect on the expression of P-glycoprotein(P-gp)in the patients.Methods A total of 78 cases of prostate cancer treated in our hospital were selected and divided into two groups according to the random number method.The control group got bicalutamide treatment,and the study group got docetaxel combined with bicalutamide treatment.The efficacy of patients and the effects on the expression of P-gp in the patients were compared between the two groups.Results After treatment,the effective rate of the study group was 92.3%,and it was significantly higher than that of the control group(38.5%)(P<0.05).In the course of treatment,the incidence of adverse reactions in the study group and the control group were 23.1% and 25.6% respectively,and there was no significant difference between the two groups(P>0.05).Before treatment,there was no significant difference in quality of life between the two groups(P>0.05).But after treatment,the scores of physical,physiology,psychology and social functions in the study group were significantly higher than those in the control group(P<0.05).After the treatment was completed,there were obviously less patients with positive expression of P-gp in the study group than in the control group(P<0.05).Conclusion Docetaxel combined wtih bicalutamide treatment can effectively control and alleviate prostate cancer for patients,and improve the quality of life.It also could improve the expression of P-gp,and do not increase adverse reactions.
作者 张冲 杨鹏 刘振湘 张淑芳 吕蔡 ZHANG Chong;YANG Peng;LIU Zhenxiang;ZHANG Shufang;LV Cai(Urinary Surgical Department,the Affiliated Haikou Hospital of Xiangya School of Medicine,Central South University,Haikou,Hainan,570208,China)
出处 《肿瘤药学》 CAS 2018年第5期779-782,共4页 Anti-Tumor Pharmacy
基金 海南省卫生厅医学科研重点课题(琼卫2013重点-04)
关键词 多西他赛 比卡鲁胺 前列腺癌 P糖蛋白 Docetaxel Bicalutamide Prostate cancer P-gp
  • 相关文献

参考文献2

二级参考文献55

  • 1谭艳红,刘冬舟,肖学吕,冯小欣,孙保东,洪小平,黄勤,蔡文虹.自身免疫性疾病合并恶性肿瘤17例分析[J].临床和实验医学杂志,2007,6(3):41-42. 被引量:10
  • 2Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [J]. CA Cancer J Clin, 2016, 66(1): 7-30. doi: 10.3322/ caac,21332.
  • 3Shi J, Zhuang Y, Liu Y, et al. Systematic analysis on the GSTM 1 null phenotype and prostate cancer risk in Chi- nese people [J]. Asian Pac J Cancer Prey, 2015, 16(5): 2009-2011.
  • 4Packer JR, Maitland NJ. The molecular and cellular origin of human prostate cancer [J]. Biochim Biophys Acta, 2016, pii: S0167-4889(16)30041-6. doi: 10,1016/ j.bbamcr,2016.02.016.
  • 5Peng YC, Joyner AL. Hedgehog signaling in prostate epi- thelial-mesenchymal growth regMation [J]. Dev Biol, 2015, 400(1): 94-104. doi: 10,1016/j.ydbio,2015.01.019.
  • 6Bai Y, Bai Y, Dong J, et al. Hedgehog Signaling in Pancre-atic Fibrosis and Cancer [J]. Medicine (Baltimore), 2016, 95(10): e2996.
  • 7Peukert S, Miller-Moslin K. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics [J]. ChemMedChem, 2010, 5(4): 500-512. doi: 10,1002/ cmdc,201000011.
  • 8Katoh Y1, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling ac- tivation [J]. Curr Mol Med, 2009, 9(7): 873-886.
  • 9Sanchez P, Hem 6 ndez AM, Stecca B, et al. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling [J]. Proc Natl Acad Sci U S A, 2004, 101(34): 12561-12566.
  • 10Sheng T, Li C, Zhang X, et al. Activation of the hedgehog pathway in advanced prostate cancer [J]. Mol Cancer, 2004, 3: 29.

共引文献15

同被引文献43

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部